TFDP3 and breast cancer: We performed a knockdown experiment of TFDP3 in mesenchymal type of breast cancer (MDA-MB-231) utilizing siRNA, and our data showed that TFDP3 was knocked down after siRNA transfection (relative amount 0.0012 vs 1.0) (Fig 8A).